Literature DB >> 21200330

Attention-deficit hyperactivity disorder in children with high intelligence quotient: results from a population-based study.

Maja Z Katusic1, Robert G Voigt, Robert C Colligan, Amy L Weaver, Kendra J Homan, William J Barbaresi.   

Abstract

OBJECTIVE: To compare the characteristics of children with attention-deficit hyperactivity disorder (ADHD) who have high intelligence quotient (IQ) versus normal and low IQ through long-term follow-up of children with ADHD from a population-based birth cohort.
METHODS: Subjects included children with research-identified ADHD (N = 379) from a birth cohort (N = 5718). Full scale IQ scores obtained between ages 6 and 18 years were used to categorize children into 3 groups: Low (IQ < 80), Normal (80 ≤ IQ < 120), and High IQ (IQ ≥ 120). Subjects were retrospectively followed up from birth until emigration, death, or high school graduation/dropout. The groups were compared on demographic characteristics, age at which ADHD case criteria were met, comorbidities, treatment, and school outcomes.
RESULTS: There were no significant differences among children with high (N = 34), normal (N = 276), or low IQ (N = 21) and ADHD in numerous characteristics, including median age at which ADHD criteria were fulfilled (9.5, 9.7, and 9.8 years); rates of comorbid learning disorders (85.3%, 78.3%, and 76.2%), psychiatric disorders (47.1%, 50.4%, and 47.6%), and substance abuse (17.6%, 23.6%, and 19.0%); and rates of stimulant treatment (79%, 75%, and 90%). In comparison to children with normal or low IQ, those with high IQ had mothers with higher educational levels (e.g., college graduation rates 44.1%, 11.6%, and 14.3%), and higher reading achievement (median national percentiles on standardized reading tests 77.0, 42.0, and 29.0, p < 0.001).
CONCLUSIONS: These findings suggest that ADHD is similar among children with high, normal, and low IQ, although high IQ may favorably mediate some outcomes such as reading achievement. Diagnosis and treatment of ADHD are important for all children, regardless of cognitive ability.

Entities:  

Mesh:

Year:  2011        PMID: 21200330      PMCID: PMC3095845          DOI: 10.1097/DBP.0b013e318206d700

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  15 in total

1.  Developmental dissociation, deviance, and delay: Occurrence of attention-deficit-hyperactivity disorder in individuals with and without borderline-to-mild intellectual disability.

Authors:  Robert G Voigt; William J Barbaresi; Robert C Colligan; Amy L Weaver; Slavica K Katusic
Journal:  Dev Med Child Neurol       Date:  2006-10       Impact factor: 5.449

2.  Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.

Authors:  William J Barbaresi; Slavica K Katusic; Robert C Colligan; Amy L Weaver; Steven J Jacobsen
Journal:  J Dev Behav Pediatr       Date:  2007-08       Impact factor: 2.225

3.  Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.

Authors:  C L Leibson; S K Katusic; W J Barbaresi; J Ransom; P C O'Brien
Journal:  JAMA       Date:  2001-01-03       Impact factor: 56.272

4.  Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn.

Authors:  S K Katusic; R C Colligan; W J Barbaresi; D J Schaid; S J Jacobsen
Journal:  Mayo Clin Proc       Date:  2001-11       Impact factor: 7.616

5.  Is attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ? Results from the MGH Longitudinal Family Studies of ADHD.

Authors:  Kevin M Antshel; Stephen V Faraone; Kimberly Stallone; Andrea Nave; Felice A Kaufmann; Alysa Doyle; Ronna Fried; Larry Seidman; Joseph Biederman
Journal:  J Child Psychol Psychiatry       Date:  2007-07       Impact factor: 8.982

6.  How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study.

Authors:  W Barbaresi; S Katusic; R Colligan; A Weaver; V Pankratz; D Mrazek; S Jacobsen
Journal:  Acta Paediatr Suppl       Date:  2004-05

7.  Temporal stability of ADHD in the high-IQ population: results from the MGH Longitudinal Family Studies of ADHD.

Authors:  Kevin M Antshel; Stephen V Faraone; Katharine Maglione; Alysa Doyle; Ronna Fried; Larry Seidman; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-07       Impact factor: 8.829

8.  Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Authors:  William J Barbaresi; Slavica K Katusic; Robert C Colligan; Amy L Weaver; Cynthia L Leibson; Steven J Jacobsen
Journal:  J Dev Behav Pediatr       Date:  2006-02       Impact factor: 2.225

9.  Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective.

Authors:  William J Barbaresi; Slavica K Katusic; Robert C Colligan; Amy L Weaver; Steven J Jacobsen
Journal:  J Dev Behav Pediatr       Date:  2007-08       Impact factor: 2.225

10.  Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder.

Authors:  Thomas W Frazier; Heath A Demaree; Eric A Youngstrom
Journal:  Neuropsychology       Date:  2004-07       Impact factor: 3.295

View more
  5 in total

1.  Differential brain development with low and high IQ in attention-deficit/hyperactivity disorder.

Authors:  Patrick de Zeeuw; Hugo G Schnack; Janna van Belle; Juliette Weusten; Sarai van Dijk; Marieke Langen; Rachel M Brouwer; Herman van Engeland; Sarah Durston
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 2.  The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.

Authors:  Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang
Journal:  Neurosci Biobehav Rev       Date:  2021-02-04       Impact factor: 9.052

Review 3.  Conceptualising compensation in neurodevelopmental disorders: Reflections from autism spectrum disorder.

Authors:  Lucy Anne Livingston; Francesca Happé
Journal:  Neurosci Biobehav Rev       Date:  2017-06-19       Impact factor: 8.989

4.  Cognitive correlates of attention-deficit hyperactivity disorder in children and adolescents with high intellectual ability.

Authors:  María Cadenas; Catharina Hartman; Stephen Faraone; Kevin Antshel; África Borges; Lianne Hoogeveen; Nanda Rommelse
Journal:  J Neurodev Disord       Date:  2020-02-10       Impact factor: 4.025

5.  Emotional and Behavioral Characteristics of Gifted Children and Their Families.

Authors:  Fatma Eren; Ayla Ömerelli Çete; Sibelnur Avcil; Burak Baykara
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.